KODIAK SCIENCES INC (KOD) Fundamental Analysis & Valuation

NASDAQ:KOD • US50015M1099

Current stock price

37 USD
-2.76 (-6.94%)
At close:
37.46 USD
+0.46 (+1.24%)
After Hours:

This KOD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. KOD Profitability Analysis

1.1 Basic Checks

  • In the past year KOD has reported negative net income.
  • In the past year KOD has reported a negative cash flow from operations.
  • In the past 5 years KOD always reported negative net income.
  • In the past 5 years KOD always reported negative operating cash flow.
KOD Yearly Net Income VS EBIT VS OCF VS FCFKOD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -99.66%, KOD is doing worse than 75.72% of the companies in the same industry.
  • KOD has a Return On Equity of -917.34%. This is amonst the worse of the industry: KOD underperforms 80.35% of its industry peers.
Industry RankSector Rank
ROA -99.66%
ROE -917.34%
ROIC N/A
ROA(3y)-52.31%
ROA(5y)-39.78%
ROE(3y)-97.26%
ROE(5y)-69.5%
ROIC(3y)N/A
ROIC(5y)N/A
KOD Yearly ROA, ROE, ROICKOD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

  • KOD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KOD Yearly Profit, Operating, Gross MarginsKOD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. KOD Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, KOD has about the same amount of shares outstanding.
  • KOD has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for KOD is higher compared to a year ago.
KOD Yearly Shares OutstandingKOD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
KOD Yearly Total Debt VS Total AssetsKOD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • KOD has an Altman-Z score of -5.84. This is a bad value and indicates that KOD is not financially healthy and even has some risk of bankruptcy.
  • KOD has a Altman-Z score of -5.84. This is in the lower half of the industry: KOD underperforms 63.97% of its industry peers.
  • A Debt/Equity ratio of 4.22 is on the high side and indicates that KOD has dependencies on debt financing.
  • With a decent Debt to Equity ratio value of 4.22, KOD is doing good in the industry, outperforming 64.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.22
Debt/FCF N/A
Altman-Z -5.84
ROIC/WACCN/A
WACCN/A
KOD Yearly LT Debt VS Equity VS FCFKOD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.78 indicates that KOD should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.78, KOD is not doing good in the industry: 78.81% of the companies in the same industry are doing better.
  • KOD has a Quick Ratio of 1.78. This is a normal value and indicates that KOD is financially healthy and should not expect problems in meeting its short term obligations.
  • KOD has a Quick ratio of 1.78. This is in the lower half of the industry: KOD underperforms 77.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.78
KOD Yearly Current Assets VS Current LiabilitesKOD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. KOD Growth Analysis

3.1 Past

  • KOD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.88%.
EPS 1Y (TTM)-12.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.1%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 12.83% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-26.75%
EPS Next 2Y-5.86%
EPS Next 3Y-1.49%
EPS Next 5Y12.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KOD Yearly Revenue VS EstimatesKOD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
KOD Yearly EPS VS EstimatesKOD Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. KOD Valuation Analysis

4.1 Price/Earnings Ratio

  • KOD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KOD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KOD Price Earnings VS Forward Price EarningsKOD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KOD Per share dataKOD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.86%
EPS Next 3Y-1.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KOD Dividend Analysis

5.1 Amount

  • No dividends for KOD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KOD Fundamentals: All Metrics, Ratios and Statistics

KODIAK SCIENCES INC

NASDAQ:KOD (3/27/2026, 8:00:03 PM)

After market: 37.46 +0.46 (+1.24%)

37

-2.76 (-6.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-26
Earnings (Next)05-12
Inst Owners92.78%
Inst Owner Change26.21%
Ins Owners4.78%
Ins Owner Change0%
Market Cap2.26B
Revenue(TTM)N/A
Net Income(TTM)-217.34M
Analysts80
Price Target36.21 (-2.14%)
Short Float %12.32%
Short Ratio10.16
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.6%
Min EPS beat(2)-11.61%
Max EPS beat(2)4.42%
EPS beat(4)2
Avg EPS beat(4)-5.48%
Min EPS beat(4)-20.72%
Max EPS beat(4)5.97%
EPS beat(8)5
Avg EPS beat(8)-4.03%
EPS beat(12)7
Avg EPS beat(12)-2.61%
EPS beat(16)9
Avg EPS beat(16)-3.73%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)60.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.75%
EPS NY rev (1m)0.42%
EPS NY rev (3m)0.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 95.26
P/tB 95.26
EV/EBITDA N/A
EPS(TTM)-4.12
EYN/A
EPS(NY)-3.77
Fwd EYN/A
FCF(TTM)-2.09
FCFYN/A
OCF(TTM)-2.08
OCFYN/A
SpS0
BVpS0.39
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -99.66%
ROE -917.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.31%
ROA(5y)-39.78%
ROE(3y)-97.26%
ROE(5y)-69.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 4.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.15%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.78
Altman-Z -5.84
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)491.62%
Cap/Depr(5y)1852.64%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.1%
EPS Next Y-26.75%
EPS Next 2Y-5.86%
EPS Next 3Y-1.49%
EPS Next 5Y12.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-19.4%
EBIT Next 3Y-10.91%
EBIT Next 5YN/A
FCF growth 1Y35.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.29%
OCF growth 3YN/A
OCF growth 5YN/A

KODIAK SCIENCES INC / KOD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KODIAK SCIENCES INC (KOD) stock?

ChartMill assigns a fundamental rating of 2 / 10 to KOD.


What is the valuation status of KODIAK SCIENCES INC (KOD) stock?

ChartMill assigns a valuation rating of 0 / 10 to KODIAK SCIENCES INC (KOD). This can be considered as Overvalued.


What is the profitability of KOD stock?

KODIAK SCIENCES INC (KOD) has a profitability rating of 0 / 10.


How financially healthy is KODIAK SCIENCES INC?

The financial health rating of KODIAK SCIENCES INC (KOD) is 5 / 10.